Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals (NASDAQ:LXRX) is one of the fastest-growing penny stocks to buy now. On November 18 at the Jefferies London Healthcare Conference 2025, Lexicon Pharmaceuticals (NASDAQ:LXRX) reiterated it is making significant progress in developing its pipeline. Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development Copyright: zneb076 / 123RF Stock Photo For starters, it is preparing for the end-of-phase two meeting with the US Food and Drug Administration for pilava ...